Trxade Health Inc
MEDS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.52M
Close$
$-9.43
1129.2% downside
Current Fair Value
1129.2% downsideOvervalued by 1129.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.52 Million |
|---|---|
| Enterprise Value | $32.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-71.5 |
| Beta | -1.52 |
| Outstanding Shares | 2,574,669 |
Return
| Return on Equity | 230324.93% |
|---|---|
| Return on Assets | -137130.30% |
| Return on Invested Capital | 706449.67% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.11 |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -1.67 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data